What is it about?
In this article, we reviewed the literature on subcutaneous belimumab focusing on safety and patients’ experiences and satisfaction. Overall, subcutaneous belimumab appears to be preferred over intravenous belimumab for a number of reasons. However, more studies are still required to prove these findings.
Featured Image
Why is it important?
To take into consideration factors that make patients choose a certain form of medications as belimumab
Perspectives
Overall, subcutaneous belimumab appears to be preferred over intravenous belimumab for a number of reasons. However, more studies are still required to prove these findings.
MD Hamdy Mohamed Abdelaziz Ahmed
University of Alabama at Birmingham
Read the Original
This page is a summary of: Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction, Patient Preference and Adherence, November 2018, Dove Medical Press,
DOI: 10.2147/ppa.s147163.
You can read the full text:
Contributors
The following have contributed to this page
